Keywords: latest, rnai, mega-deal, sees, takeda, team, up

Latest RNAi mega-deal sees Takeda team up with Alnylam for up to $1.0 billion

Article | 02 June 2008

Print This

Alnylam Pharmaceuticals has entered a deal with Japan's largest drugmaker, Takeda, that could see the US RNA interference specialist earn ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in